Active Ingredient: CETIRIZINE HYDROCHLORIDE
Proprietary Name: ZERVIATE
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: EQ 0.24% BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N208694
Product Number: 001
Approval Date: May 30, 2017
Applicant Holder Full Name: HARROW EYE LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
